Regulation and metabolic functions of mTORC1 and mTORC2
Cells metabolize nutrients for biosynthetic and bioenergetic needs to fuel growth and
proliferation. The uptake of nutrients from the environment and their intracellular metabolism …
proliferation. The uptake of nutrients from the environment and their intracellular metabolism …
Targeting mTOR and metabolism in cancer: lessons and innovations
Cancer cells support their growth and proliferation by reprogramming their metabolism in
order to gain access to nutrients. Despite the heterogeneity in genetic mutations that lead to …
order to gain access to nutrients. Despite the heterogeneity in genetic mutations that lead to …
Phosphorylation of PDHA by AMPK drives TCA cycle to promote cancer metastasis
Cancer metastasis accounts for the major cause of cancer-related deaths. How
disseminated cancer cells cope with hostile microenvironments in secondary site for full …
disseminated cancer cells cope with hostile microenvironments in secondary site for full …
Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy
Z Zheng, J Su, X Bao, H Wang, C Bian, Q Zhao… - Frontiers in …, 2023 - frontiersin.org
Radiotherapy (RT) is an effective treatment option for cancer patients, which induces the
production of reactive oxygen species (ROS) and causes oxidative stress (OS), leading to …
production of reactive oxygen species (ROS) and causes oxidative stress (OS), leading to …
Novel systemic treatment modalities including immunotherapy and molecular targeted therapy for recurrent and metastatic head and neck squamous cell carcinoma
Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancers
worldwide. More than half of patients with HNSCC eventually experience disease …
worldwide. More than half of patients with HNSCC eventually experience disease …
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
L Zhang, Y Li, Q Wang, Z Chen, X Li, Z Wu, C Hu… - Molecular Cancer, 2020 - Springer
Abstract Background PI3K/AKT is a vital signaling pathway in humans. Recently, several
PI3K/AKT inhibitors were reported to have the ability to reverse cancer multidrug resistance …
PI3K/AKT inhibitors were reported to have the ability to reverse cancer multidrug resistance …
Impacts of oxidative stress and PI3K/AKT/mTOR on metabolism and the future direction of investigating fucoidan-modulated metabolism
The critical factors for regulating cancer metabolism are oxidative stress and
phosphoinositide-3-kinase/AKT serine-threonine kinase/mechanistic target of the rapamycin …
phosphoinositide-3-kinase/AKT serine-threonine kinase/mechanistic target of the rapamycin …
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
V Ecker, M Stumpf, L Brandmeier, T Neumayer… - Nature …, 2021 - nature.com
Current therapeutic approaches for chronic lymphocytic leukemia (CLL) focus on the
suppression of oncogenic kinase signaling. Here, we test the hypothesis that targeted …
suppression of oncogenic kinase signaling. Here, we test the hypothesis that targeted …
[HTML][HTML] Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells–a potential contribution to the predictive, preventive …
A Mazurakova, L Koklesova, SH Csizmár… - Journal of Advanced …, 2024 - Elsevier
Background Cancer management faces multiple obstacles, including resistance to current
therapeutic approaches. In the face of challenging microenvironments, cancer cells adapt …
therapeutic approaches. In the face of challenging microenvironments, cancer cells adapt …
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
E Hasanov, DN Yeboa, MD Tucker… - CA: A Cancer …, 2022 - Wiley Online Library
Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited
understanding of brain metastasis tumor and immune biology, drivers of resistance to …
understanding of brain metastasis tumor and immune biology, drivers of resistance to …